Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer

Molecular Cell - Tập 49 Số 3 - Trang 474-486 - 2013
Ana Chocarro‐Calvo1, José Manuel García-Martínez1, Soraya Ardila-González1, Antonio De la Vieja2, Custodia García‐Jiménez1
1Departamento de Fisiología y Bioquímica, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, 28922 Alcorcon, Madrid, Spain
2Área de Biología Celular y Desarrollo, Instituto de Salud Carlos III, Centro Nacional de Microbiología, 28220 Majadahonda, Madrid, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Anagnostou, 2008, Glucose induces an autocrine activation of the Wnt/beta-catenin pathway in macrophage cell lines, Biochem. J., 416, 211, 10.1042/BJ20081426

Andrews, 1991, A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells, Nucleic Acids Res., 19, 2499, 10.1093/nar/19.9.2499

Audrito, 2011, Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network, Cancer Res., 71, 4473, 10.1158/0008-5472.CAN-10-4452

Bafico, 2004, An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells, Cancer Cell, 6, 497, 10.1016/j.ccr.2004.09.032

Barker, 2009, Crypt stem cells as the cells-of-origin of intestinal cancer, Nature, 457, 608, 10.1038/nature07602

Clevers, 2006, Wnt/beta-catenin signaling in development and disease, Cell, 127, 469, 10.1016/j.cell.2006.10.018

Delmas, 2007, Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development, Genes Dev., 21, 2923, 10.1101/gad.450107

Dowling, 2007, Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells, Cancer Res., 67, 10804, 10.1158/0008-5472.CAN-07-2310

Efeyan, 2010, mTOR and cancer: many loops in one pathway, Curr. Opin. Cell Biol., 22, 169, 10.1016/j.ceb.2009.10.007

Firestein, 2008, The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth, PLoS ONE, 3, e2020, 10.1371/journal.pone.0002020

Flatt, 2006, Nutrient regulation of pancreatic beta-cell function in diabetes: problems and potential solutions, Biochem. Soc. Trans., 34, 774, 10.1042/BST0340774

Gao, 2009, Diabetes mellitus: a “true” independent risk factor for hepatocellular carcinoma?, HBPD INT, 8, 465

García-Jiménez, 2010, Wnt and incretin connections, Vitam. Horm., 84, 355, 10.1016/B978-0-12-381517-0.00014-X

García-Martínez, 2009, WNT/beta-catenin increases the production of incretins by entero-endocrine cells, Diabetologia, 52, 1913, 10.1007/s00125-009-1429-1

Gerber, 2009, Background review paper on total fat, fatty acid intake and cancers, Ann. Nutr. Metab., 55, 140, 10.1159/000229000

Giovannucci, 2010, Diabetes and cancer: a consensus report, Diabetes Care, 33, 1674, 10.2337/dc10-0666

Gnagnarella, 2008, Glycemic index, glycemic load, and cancer risk: a meta-analysis, Am. J. Clin. Nutr., 87, 1793, 10.1093/ajcn/87.6.1793

Gualberto, 2009, Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions, Oncogene, 28, 3009, 10.1038/onc.2009.172

Hecht, 2000, The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates, EMBO J., 19, 1839, 10.1093/emboj/19.8.1839

Hillon, 2010, Obesity, type 2 diabetes and risk of digestive cancer, Gastroenterol. Clin. Biol., 34, 529, 10.1016/j.gcb.2010.07.021

Huber, 1996, Nuclear localization of beta-catenin by interaction with transcription factor LEF-1, Mech. Dev., 59, 3, 10.1016/0925-4773(96)00597-7

Khandekar, 2011, Molecular mechanisms of cancer development in obesity, Nat. Rev. Cancer, 11, 886, 10.1038/nrc3174

Kim, 2001, New evidence that nuclear import of endogenous beta-catenin is LEF-1 dependent, while LEF-1 independent import of exogenous beta-catenin leads to nuclear abnormalities, Cell Biol. Int., 25, 1149, 10.1006/cbir.2001.0799

Kinzler, 1996, Lessons from hereditary colorectal cancer, Cell, 87, 159, 10.1016/S0092-8674(00)81333-1

Korinek, 1998, Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse, Mol. Cell. Biol., 18, 1248, 10.1128/MCB.18.3.1248

Lévy, 2004, Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction, Mol. Cell. Biol., 24, 3404, 10.1128/MCB.24.8.3404-3414.2004

Liu, 2008, Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation, J. Biol. Chem., 283, 8723, 10.1074/jbc.M706105200

Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262

Lyssenko, 2008, The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update, Curr. Opin. Clin. Nutr. Metab. Care, 11, 385, 10.1097/MCO.0b013e328304d970

Ma, 2005, Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression, Oncogene, 24, 3619, 10.1038/sj.onc.1208433

McIntosh, 2009, Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP), Vitam. Horm., 80, 409, 10.1016/S0083-6729(08)00615-8

Morton, 2011, A FAK-PI-3K-mTOR axis is required for Wnt-Myc driven intestinal regeneration and tumorigenesis, Cell Cycle, 10, 173, 10.4161/cc.10.2.14350

Nauck, 1993, Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations, J. Clin. Endocrinol. Metab., 76, 912

Orsulic, 1996, An in vivo structure-function study of armadillo, the beta-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling, J. Cell Biol., 134, 1283, 10.1083/jcb.134.5.1283

Pisani, 2008, Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies, Arch. Physiol. Biochem., 114, 63, 10.1080/13813450801954451

Prieve, 1999, Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression, Mol. Cell. Biol., 19, 4503, 10.1128/MCB.19.6.4503

Renehan, 2008, Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies, Lancet, 371, 569, 10.1016/S0140-6736(08)60269-X

Sauve, 2003, Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry, Biochemistry, 42, 9249, 10.1021/bi034959l

Saxena, 2006, Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals, Diabetes, 55, 2890, 10.2337/db06-0381

Tennant, 2010, Targeting metabolic transformation for cancer therapy, Nat. Rev. Cancer, 10, 267, 10.1038/nrc2817

Vigneri, 2009, Diabetes: diabetes therapy and cancer risk, Nat. Rev. Endocrinol., 5, 651, 10.1038/nrendo.2009.219

von Kries, 2000, Hot spots in beta-catenin for interactions with LEF-1, conductin and APC, Nat. Struct. Biol., 7, 800, 10.1038/79039

Warburg, 1967, [On growth of cancer cells in media in which glucose is replaced by galactose], Hoppe Seylers Z. Physiol. Chem., 348, 1686, 10.1515/bchm2.1967.348.1.1686

Wolf, 2002, Acetylation of beta-catenin by CREB-binding protein (CBP), J. Biol. Chem., 277, 25562, 10.1074/jbc.M201196200

Wu, 2010, GSK3: a multifaceted kinase in Wnt signaling, Trends Biochem. Sci., 35, 161, 10.1016/j.tibs.2009.10.002

Xu, 2007, Mechanistic insights from structural studies of beta-catenin and its binding partners, J. Cell Sci., 120, 3337, 10.1242/jcs.013771